Pricing Log in Create free account

CytoMed Therapeutics Limited (GDTC) vs SeaStar Medical Holding Corporation (ICU)

CytoMed Therapeutics Limited and SeaStar Medical Holding Corporation are both Biotechnology companies. CytoMed Therapeutics Limited and SeaStar Medical Holding Corporation are of similar size ($10.4M and $10.2M). CytoMed Therapeutics Limited has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, CytoMed Therapeutics Limited leads on 9 and SeaStar Medical Holding Corporation on 3.

Valuation

Metric GDTC ICU Biotechnology median
P/E n/m n/m 10.60
P/S n/m 4.55 9.40
P/B 0.52 1.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.99 9.02
Earnings yield (35.00%) (204.71%) (32.88%)
Free cash flow yield (0.42%) (175.54%) (23.13%)

Profitability

Metric GDTC ICU Biotechnology median
Gross margin 0.00% 92.64% 68.51%
Operating margin — (816.75%) 0.00%
Net margin 0.00% (795.50%) 0.00%
Free cash flow margin 0.00% (799.36%) 0.00%
Return on equity 0.00% (356.87%) (51.96%)
Return on assets 0.00% (160.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GDTC ICU Biotechnology median
Revenue growth (TTM) — 123.63% 6.76%
EPS growth (last fiscal year) (68.75%) 91.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GDTC ICU Biotechnology median
Debt to equity 80.30 0.00 0.00
Current ratio 2.64 1.89 4.97
Net debt to EBITDA 0.86 0.99 1.01

Dividend

Metric GDTC ICU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GDTC ICU Biotechnology median
Market cap 10.41m 10.20m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack